An Observational Study of Aducanumab-avwa in Participants With Alzheimer's Disease in the US

Clinical trial NCT05097131 · TERMINATED

Trial details

NCT number: NCT05097131
Sponsor: Biogen
Status: TERMINATED
Study type: OBSERVATIONAL

Alzheimers Disease

Start date: 2021-11-18
Primary completion: 2022-05-20
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.